Market Research Logo

Kuwait Pharmaceuticals and Healthcare Report Q4 2015

Kuwait Pharmaceuticals and Healthcare Report Q4 2015

BMI View: Kuwait's pharmaceutical sector will remain dominated by multinational drugmakers given thepreference for branded products among both prescribers and consumers. Development of the local genericssector will be stimulated by the implementation of cost-containment measures within the healthcare sector.Headline Expenditure Projections

Pharmaceuticals: From KWD287mn (USD1.01bn) in 2014 to KWD300mn (USD1.01bn) in 2015;+4.7% in local currency terms and +0.6% in US dollar terms. Forecast unchanged from Q315.

Healthcare: From KWD1.56bn (USD5.49bn) in 2014 to KWD1.67bn (USD5.64bn) in 2015; +6.9% inlocal currency terms and +2.7% in US dollar terms. Forecast unchanged from Q315.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kuwait 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kuwait 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kuwait 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Expenditure Breakdown
Table: Economic Activity (Kuwait 2010-2019)
Industry Risk Reward Indices
Middle East and Africa Risk/Reward Index - Q4 2015
Kuwait Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Sector Developments
Healthcare Insurance
Research and Development
Regulatory Development
Regulatory Regime
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Competitive Landscape
Company Profile
Advanced Technology Company
Bader Sultan & Bros
GlaxoSmithKline
Johnson & Johnson
Kuwait-Saudi Pharmaceutical Industries (KSP)
Merck & Co
Novartis
Pfizer
Safwan Trading And Contracting Company
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Kuwait 1990-2025)
Table: Key Population Ratios (Kuwait 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kuwait 1990-2025)
Table: Population By Age Group (Kuwait 1990-2025)
Table: Population By Age Group % (Kuwait 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report